Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2. - Wikidata - wikimedia - TriplyDB

Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2.

Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2.

http://www.wikidata.org/entity/Q34982664

about

A role for the Ankyrin repeat containing protein Ankrd17 in Nod1- and Nod2-mediated inflammatory responses The innate immune sensor NLRC3 attenuates Toll-like receptor signaling via modification of the signaling adaptor TRAF6 and transcription factor NF-κB OTULIN restricts Met1-linked ubiquitination to control innate immune signaling IAPs regulate the plasticity of cell migration by directly targeting Rac1 for degradation ITCH K63-ubiquitinates the NOD2 binding protein, RIP2, to influence inflammatory signaling pathways ARTS and Siah collaborate in a pathway for XIAP degradation cIAP1/2 are direct E3 ligases conjugating diverse types of ubiquitin chains to receptor interacting proteins kinases 1 to 4 (RIP1-4)A novel motif in the Crohn's disease susceptibility protein, NOD2, allows TRAF4 to down-regulate innate immune responses Ubiquitin signaling in immune responses Ubiquitin-Mediated Regulation of Cell Death, Inflammation, and Defense of Homeostasis Regulation of Cell Death by IAPs and Their Antagonists Inhibitor of apoptosis (IAP) proteins-modulators of cell death and inflammation The role of ubiquitylation in immune defence and pathogen evasion T-regulatory cells in primary immune deficiencies Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases NOD-Like Receptors: Master Regulators of Inflammation and Cancer IAPs: a central element in the NF-κB activating signaling pathway Ubiquitin in the immune system Innate immune signaling in defense against intestinal microbes RIP2 activity in inflammatory disease and implications for novel therapeutics Regulation of inflammatory and antiviral signaling by A20.The ubiquitin system: a critical regulator of innate immunity and pathogen-host interactions Deubiquitinases: Novel Therapeutic Targets in Immune Surveillance?International Union of Basic and Clinical Pharmacology. XCVI. Pattern recognition receptors in health and disease Linear ubiquitination in immunity CYLD Limits Lys63- and Met1-Linked Ubiquitin at Receptor Complexes to Regulate Innate Immune Signaling Pellino3 ubiquitinates RIP2 and mediates Nod2-induced signaling and protective effects in colitis The cofilin phosphatase slingshot homolog 1 (SSH1) links NOD1 signaling to actin remodeling Gene expression studies of a human monocyte cell line identify dissimilarities between differently manufactured glatiramoids Engagement of nucleotide-binding oligomerization domain-containing protein 1 (NOD1) by receptor-interacting protein 2 (RIP2) is insufficient for signal transduction The c-Jun N-terminal kinase (JNK)-binding protein (JNKBP1) acts as a negative regulator of NOD2 protein signaling by inhibiting its oligomerization process RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL Signaling to NF-kappaB: regulation by ubiquitination.Virus-triggered ubiquitination of TRAF3/6 by cIAP1/2 is essential for induction of interferon-beta (IFN-beta) and cellular antiviral response Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs)Bacterial DNA Protects Monocytic Cells against HIV-Vpr-Induced Mitochondrial Membrane Depolarization.E3 Ubiquitin ligase ZNRF4 negatively regulates NOD2 signalling and induces tolerance to MDP.NOD-like receptors in intestinal homeostasis and epithelial tissue repair.IAP inhibitors enhance co-stimulation to promote tumor immunity.Inhibitor of Apoptosis (IAP) proteins as drug targets for the treatment of cancer

P2860

Q24293733-BAA4F57C-C4F0-46DE-9962-B5D929922F75 Q24294960-1FAE15A2-FD11-4223-9FCB-8898577060A5 Q24296844-AB416FD4-1A8F-4AE3-A3EC-3C43B6F4C033 Q24298339-E39FFAFD-843C-40B3-987E-C110AE784F56 Q24313068-2FBCEF0F-E5F1-4E67-AADA-5CC30711088E Q24321222-730226D5-A9F6-4C72-87A7-8C6EEBFF5A95 Q24338276-722A1513-388B-473B-AFDE-1C96354305B4 Q24594581-A4E30449-2BC1-45AE-88D6-17682AB073CA Q26751376-E9C14CDC-3798-486C-B764-CC4940F2A080 Q26782575-80859E89-7DD2-4168-BD22-0A453097FBC3 Q26782579-18289719-D7A5-4900-A52C-E9484E356E0F Q26824586-08C932AE-E41E-45E8-8A4A-C2E8B2259601 Q26860775-DDDEB0D1-9CFB-4D33-92CE-C6CB9992DA06 Q26862699-92CAD64C-2739-4A8B-9AF7-1CC2139C7988 Q26864035-68316201-310A-43C4-9699-A58EFB00CDAB Q26865199-1CE28CF6-3568-4B88-AAAC-889534FDCA5C Q26866467-B9C25BDA-71D0-4140-8814-DC7334B71ED9 Q26998711-510108C3-8D3E-4DA2-A285-4479B3493CB1 Q27002611-0675560F-FAE2-4779-8528-B50EB194C74C Q27025050-B4A06FA2-47F4-4EC9-A929-4FA85914E1F7 Q27690854-5EEB0381-CAA5-4199-88A1-C78D28F11C07 Q28067104-9A1A40DC-6609-4675-873F-945EF9D6C960 Q28069021-0FC8CF08-E345-4132-B21E-42A9C9FAFCDA Q28081406-857CB1AF-B160-4916-88DE-D0BBC7756773 Q28082899-4CC86A3A-936E-419A-946D-ACD9CC1CFA49 Q28117541-C9EDA27A-4B48-485A-922C-9601D94EE13F Q28513622-F484B060-E89B-48ED-924B-3E49FFAC6A49 Q28542810-54B9E633-440C-4813-B719-6D887C1BB4EA Q28647160-9BC36D4D-0A52-4021-AF14-B43C03CD64FB Q28654551-351DDE5F-38F1-4245-BE63-6E98121BB3D2 Q28975740-B4CAA813-7EC6-4AF2-B2D1-CB46C8AAEEB5 Q30623992-C348341F-D8D9-4248-BCEC-0F21AB41E06B Q33693806-9D03BB55-15B6-41BC-BAA7-EFCA4604957D Q33744532-2BD04016-19F0-459C-B96F-FAE77864A1F3 Q33841579-C8AE2065-E78B-4F54-9024-047EAF11011C Q33846203-F67B51CA-9810-436C-A716-32452E380D10 Q33861394-63307562-BE5E-48BE-BEB6-CD73D50C5D34 Q33907548-0852CE18-1F0F-48EB-9AA3-E3A38AEB4E3B Q34161533-8AA8C8E9-37B3-4E56-B596-3B1B0571EA90 Q34167279-449253BB-253B-49A6-B597-B85758980E30

P2860

Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2.

http://www.wikidata.org/entity/Q34982664

description

2009 nî lūn-bûn

@nan

2009 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Cellular inhibitors of apoptos ...... ition receptors NOD1 and NOD2.

@ast

Cellular inhibitors of apoptos ...... ition receptors NOD1 and NOD2.

@en

Cellular inhibitors of apoptos ...... ition receptors NOD1 and NOD2.

@nl

type

label

Cellular inhibitors of apoptos ...... ition receptors NOD1 and NOD2.

@ast

Cellular inhibitors of apoptos ...... ition receptors NOD1 and NOD2.

@en

Cellular inhibitors of apoptos ...... ition receptors NOD1 and NOD2.

@nl

prefLabel

Cellular inhibitors of apoptos ...... ition receptors NOD1 and NOD2.

@ast

Cellular inhibitors of apoptos ...... ition receptors NOD1 and NOD2.

@en

Cellular inhibitors of apoptos ...... ition receptors NOD1 and NOD2.

@nl

P1433

Q34982664-F6FD0F93-1DE8-4AF9-BDBE-893F2FC2C3EE

P1476

Q34982664-789CE8F7-23B5-48C4-9E6B-04746B51F894

P2093

Q34982664-1143372F-1F93-4478-9E03-05CF6C5B3D93

Q34982664-21C89CE5-27B1-4239-A336-645DF06F2F3F

Q34982664-3F4CFD14-C786-4666-BE0A-E18ED46BFA03

Q34982664-B28C9C3A-9B6B-4E91-8E36-51A01EB2FFCE

Q34982664-E49E94D7-A6F2-4D50-92E1-79280C9D5557

P304

Q34982664-13ECFC68-9764-4768-9278-4426E1BFE84A

P31

Q34982664-BFDCB229-DA31-4A3F-8BA7-1BE924EF2DC0

P356

Q34982664-7946C0A1-A469-419D-9497-05F8A8B56DFB

P407

Q34982664-545AD123-BD34-4C26-8599-759227C0C141

P433

Q34982664-AF75DE31-2AF4-405F-9A45-5F0DCBA12F05

P478

Q34982664-352F3B58-54ED-45C0-A71F-8ABB96168E7F

P50

Q34982664-C9E034C4-C9E2-4F26-BEAC-DB453AB05C14

P577

Q34982664-2F4150FC-E1B2-4C99-8E27-A8EC1C4B1AB2

P5875

Q34982664-309FC6B8-CE7E-4292-850E-FF32E4F34C8B

P698

Q34982664-988E6D3B-F1C7-4569-9D8A-C23693FEEC7C

P356

J.IMMUNI.2009.04.011

P1433

P1476

Cellular inhibitors of apoptos ...... nition receptors NOD1 and NOD2

@en

P2093

Karine Doiron

http://www.w3.org/2001/XMLSchema#string

Katherine Labbé

http://www.w3.org/2001/XMLSchema#string

Maya Saleh

http://www.w3.org/2001/XMLSchema#string

Philip A Barker

http://www.w3.org/2001/XMLSchema#string

Robert G Korneluk

http://www.w3.org/2001/XMLSchema#string

P304

789-801

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IMMUNI.2009.04.011

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Mathieu Jm Bertrand

P577

2009-05-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26235832

http://www.w3.org/2001/XMLSchema#string

P698

19464198

http://www.w3.org/2001/XMLSchema#string